
Clinical Trial Endpoints in Oncology
OncoPharm
00:00
Why Use Surrogate Endpoints
John Bazar asks why trials use surrogates and explains faster results, sequencing, crossover, and disease aggressiveness considerations.
Play episode from 05:12
Transcript


